Latest News and Press Releases

LEIDEN, The Netherlands, April 14, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its financial results for the first quarter of 2003. -...

STOCKHOLM, Sweden, Feb. 13, 2003 (PRIMEZONE) -- Biora AB (publ) (Other OTC:BIORY) 4th Qtr 4th Qtr Full Year Full Year 2002 ...

STOCKHOLM, Sweden, Feb. 12, 2003 (PRIMEZONE) -- Arexis AB has received approval for a breakthrough patent application in Europe, covering a new method for treating the most common skin disorders. The...

UPPSALA SCIENCE PARK, Sweden, Oct. 21, 2002 (PRIMEZONE) -- Gyros AB today announced the finalization of agreements with distributors, B & L Systems in BeNeLux and Bucher Biotec in Switzerland, to...

GENT, Belgium, Oct. 17, 2002 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced the first liver histology results of its E1-based therapeutic candidate vaccine in 24 patients chronically...

HOERSHOLM, Denmark, Oct. 2, 2002 (PRIMEZONE) -- Pharmexa A/S (Copenhagen:PHARMX) today announced that ING Financial Markets has initiated coverage of its stock. The research report, published today,...

UPPSALA, Sweden, Sept. 24, 2002 (PRIMEZONE) -- Erika Kjellberg Eriksson has been appointed acting Chief Financial Officer at Q-Med (Stockholm:QMED) and thereby replaces the former Chief Financial...

LONDON, Sept. 17, 2002 (PRIMEZONE) -- Interview available now on www.cantos.com with Stephen P A Fodor, Affymetrix (Nasdaq:AFFX) Chairman and Chief Executive Officer. Stephen tackles issues around...

OSLO, Norway, Aug. 20, 2002 (PRIMEZONE) -- Log on to http://www.cantos.com for: Amersham -- interim report. -- Interviews with Sir William Castell, Amersham Chief Executive, Dr. John...

ALLSCHWIL/BASEL, Switzerland, Aug. 15, 2002 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today preliminary results from RAPIDS-1, evaluating the efficacy and safety of Tracleer(TM) in the...